The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis

The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis

Abstract Background and aim The present study aimed to evaluate the use of 18F-2-[18F]-fluoro-2-deoxy-d-glucose (FDG) PET/MRI (Positron emission tomography-computed tomography) in predicting the pathological response to neoadjuvant chemotherapy (NAC) in patients with breast cancer (BC) compared to t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Milad Ghanikolahloo, Hayder Jasim Taher, Ayoob Dinar Abdullah, Mahsa Asadi Anar, Ali Tayebi, Rahil Rahimi, Faranak Olamaeian, Nima Rahimikashkooli, Nima Kargar
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Radiation Oncology
Subjects:	Neoadjuvant chemotherapy 18F-FDG PET/MRI Pathological complete response Breast cancer
Online Access:	https://doi.org/10.1186/s13014-024-02507-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of pre-treatment F-18 FDG PET/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy
by: Feray Aras, et al.
Published: (2025-08-01)

Total Lesion Glycolysis (TLG) on 18F-FDG PET/CT as a Potential Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy: A Retrospective Study
by: Handan Tokmak, et al.
Published: (2025-07-01)

[18F]-FDG PET-CT in Malignant Melanoma
by: Teodora Sidonia Mititelu, et al.
Published: (2025-05-01)

18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
by: Teik Hin Tan, et al.
Published: (2022-06-01)

An incidental pulmonary amyloidoma detected during 18F-FDG PET/CT assessment of large vessel vasculitis
by: George Ashton, MBChB, BMedSci, et al.
Published: (2025-07-01)

Occult tumour-induced osteomalacia causing lesion detected by FDG-PET/CT scan
by: Nitin Gupta, et al.
Published: (2020-04-01)

Prognostic value of FDG PET/CT in special types of breast cancer with non-favorable histology
by: Mutsumi Fujimoto, et al.
Published: (2025-07-01)

[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease
by: Virginia Pelagotti, et al.
Published: (2025-09-01)

<sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer
by: A. V. Leontyev, et al.
Published: (2022-12-01)

The baseline 18F-FDG PET/CT imaging features in pediatric patients with congenital neuroblastoma
by: Keyu Zhang, et al.
Published: (2025-08-01)

<sup>18</sup>F-FDG PET/CT Findings in Glandular Tularemia
by: Freja Gustafsson, et al.
Published: (2025-05-01)

Assessment of the Effect of Blood Glucose Levels on Standardized Uptake Value (SUV) and 18F-FDG Uptake at Tumors and Normal PET Examinations
by: Marwa Safa Riyadh, et al.
Published: (2025-06-01)

Diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in preoperative staging of locoregional urinary bladder cancer: a systematic review and Meta-Analysis
by: Ahmed Saad Abdlkadir, et al.
Published: (2025-07-01)

18F-FDG PET/CT-assisted diagnosis of mediastinal poorly differentiated neuroendocrine lung cancer presenting with bone metastasis as the initial symptom
by: Lingyu Hou, et al.
Published: (2025-05-01)

Evaluation of the efficacy of FDG-PET/CT in assessing the effects of BMMSC treatment in aged rhesus monkeys
by: Yaohui Zhang, et al.
Published: (2025-08-01)

Ewing's Sarcoma Omental Odyssey: Unraveling Rare Metastasis and Unforeseen Treatment Outcome on FDG PET/CT: Case Report with Review of Literature
by: Prakash Singh, et al.

Utility of 18F-FDG PET/CT and Cardiac MRI in early Cardiac Sarcoidosis
by: Muthiah Subramanian, et al.
Published: (2025-07-01)

18F-FDG dose reduction using deep learning-based PET reconstruction
by: Ryuji Akita, et al.
Published: (2025-07-01)

Detection of vertebral insufficiency fractures on 18F-FDG PET/CT following radiation therapy for oesophageal cancer
by: George Ashton, MBChB, BMedSci, et al.
Published: (2025-09-01)

18F-FDG PET and combined diffusion weighted MRI features in pleural infection: A case report
by: KyungAh Chun, MD, PhD
Published: (2025-09-01)

“Stocking Pattern Metabolic Captivity” of Legs on 18F-FDG PET-CT in Necrotizing Fasciitis: Potential Complimentary Role in Differential Diagnosis and Assessment of Disease Extent in a Life-Threatening Condition
by: Sunita Nitin Sonavane, et al.
Published: (2022-10-01)

Total-body 18F-FDG PET/CT: more choices to promote clinical scanning efficiency
by: Jie Xiao, et al.
Published: (2025-08-01)

Fluorodeoxyglucose (FDG) PET/CT imaging analysis and clinical treatment evaluation in patients with SMARCA4-deficient tumors: case reports of four patients
by: Xueqin Zhao, et al.
Published: (2025-06-01)

Enhanced glucose metabolism mediated by CD147 is associated with 18F‐FDG PET/CT imaging in lung adenocarcinoma
by: Yufan Zhang, et al.
Published: (2020-05-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)

Impact of routine FDG-PET/CT on locoregional treatment decisions in breast cancer patients receiving preoperative systemic therapy
by: Jetske L.B. Gunster, et al.
Published: (2025-06-01)

A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer
by: Matthew J. Roberts, et al.
Published: (2025-07-01)

Utility of [18F]FDG PET/CT in sarcoidosis management: A retrospective case series
by: Mourad Zekri, et al.
Published: (2025-04-01)

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-04-01)

An Unusual FDG-PET/CT Documentation in Aleukemic Leukemia Cutis: Atypical Penile, Scrotal, and Leg Muscles Involvement
by: Sunita Nitin Sonavane, et al.
Published: (2022-09-01)

Alterations in cerebral glucose metabolism measured by FDG PET in subjects performing a meditation practice based on clitoral stimulation [version 2; peer review: 2 approved, 1 approved with reservations]
by: Nancy A. Wintering, et al.
Published: (2023-12-01)

Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica
by: Andreas Wiggers Nielsen, et al.
Published: (2025-04-01)

The predictive power of baseline metabolic and volumetric [18F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapy
by: Emil Novruzov, et al.
Published: (2025-06-01)

Application of <sup>18</sup>F-FDG Positron Emission Tomography/Magnetic Resonance in Evaluation of Oropharyngeal Carcinoma
by: Yilin Shen, et al.
Published: (2025-04-01)

Comparison of 18F-NaF Imaging, 99mTc-MDP Scintigraphy, and 18F-FDG for Detecting Bone Metastases
by: Habibollah Dadgar, et al.
Published: (2022-03-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options
by: Yu. S. Sidorenko, et al.
Published: (2014-07-01)